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Can carotid endarterectomy improve metabolic
status in patients with asymptomatic internal
carotid artery flow lesion? Studies with localized in
vivo proton magnetic resonance spectroscopy
Geun Eun Kim, MD,a Jung Hee Lee, PhD,b and Yong Pil Cho, MD,c Seoul and Kangnung, Korea
Purpose: Carotid endarterectomy (CEA) has proven to be effective in the prevention of stroke in patients with significant
internal carotid artery (ICA) stenosis. However, whether increased cerebral blood flow after CEA improves the cerebral
metabolism in patients with asymptomatic ICA flow lesions is unknown. Localized in vivo proton magnetic resonance
spectroscopy (1H-MRS) has been used to measure the metabolic status of the human brain in a totally noninvasive
manner. The aim of this study was to investigate the cerebral metabolism after CEA in patients with asymptomatic ICA
flow lesions and no visible infarction on magnetic resonance imaging (MRI).
Materials and Methods: We designed a prospective study to investigate the metabolic changes in the middle cerebral artery
(MCA) territory with 1H-MRS for 18 consecutive patients with asymptomatic severe stenosis of the ICA (>70%
reduction in diameter) and for 16 healthy control subjects. The 18 patients with ICA flow lesion and no visible infarction
on MRI who underwent CEA were evaluated before and 7 days after surgery (CEA group). The 16 control subjects had
never had a cerebral event, and brain MRI and carotid duplex scan study results were normal in all (control group).
Results: Preoperative ICA volume flow was severely decreased to less than 150 mL/min in all 18 patients, in comparison
with our laboratory normal value of matched age group of 250 to 300 mL/min. After CEA, ICA volume flow was
increased to greater than 300 mL/min in all patients (P  .00). For patients in the CEA group, preoperative
N-acetylaspartate/creatine and choline/creatine ratios in the MCA territory were slightly decreased compared with the
healthy subjects in the control group but were within normal limits. However, the postoperative values of N-
acetylaspartate/creatine and choline/creatine ratios in the ipsilateral MCA territory were significantly increased as
compared with the preoperative values (P < .05). In the contralateral side, the postoperative increase of choline/creatine
ratio and the decrease of myo-inositol/creatine ratio were statistically significant as compared with the preoperative values
(P < .05).
Conclusion: CEA seems to improve the cerebral metabolic status in patients with asymptomatic ICA flow lesions and no
visible infarction on MRI. (J Vasc Surg 2002;36:559-64.)
The North American Symptomatic Carotid Endarter-
ectomy Trial1 and the European Carotid Surgery Trial2
have effectively shown that carotid endarterectomy (CEA)
can prevent stroke and death in patients with symptomatic
internal carotid artery (ICA) stenosis. The benefit of oper-
ation is presently confined to those patients with at least
70% ICA stenosis. Although controversies exist,3-5 dis-
abling stoke (or death) can be prevented with CEA in
patients with asymptomatic ICA stenosis as shown in the
Asymptomatic Carotid Artery Study.5
Localized in vivo proton magnetic resonance spectros-
copy (1H-MRS) has been used to measure the metabolic
status of the human brain in a totally noninvasive manner;
thus, it is often called “noninvasive biochemical assay.”
Until the advent of MRS, no direct noninvasive assay of the
cerebral metabolites was available. MRS is more sensitive
than magnetic resonance imaging (MRI) in detection of
ischemic damage with measurement of the metabolic
changes that may happen before the anatomic changes.
Therefore, 1H-MRS may also provide valuable clinical in-
formation in diagnosis and management of cerebral hypo-
perfusion at a much earlier stage. Previously, for the pa-
tients with symptomatic ICA flow lesion and cerebral
infarction, we showed with 1H-MRS that CEA seems to
improve the cerebral metabolism resulting from the in-
creased cerebral perfusion at the periinfarct area.6 The aim
of this study was to investigate the changes of cerebral
metabolism after CEA in patients with asymptomatic ICA
flow lesion and no visible infarction on MRI.
MATERIALS AND METHODS
We investigated 18 consecutive patients with asymp-
tomatic severe ICA stenosis (70% reduction in diameter)
and 16 control subjects without any medical risk factors
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between June 1999 and July 2000. Eighteen patients with
ICA flow lesion and no visible infarction on MRI (mean
age, 64 years; range, 53 to 75 years; male:female, 17:1)
who underwent CEA were evaluated with 1H-MRS before
and 7 days after surgery (CEA group). In the CEA group,
all patients underwent carotid duplex scanning and either
magnetic resonance angiography or conventional cerebral
angiography before surgery. Risk factors included con-
tralateral ICA severe stenosis or occlusion (10 cases,
55.6%), ischemic heart disease (eight cases, 50%), smoking
(10 cases, 55.6%), hypertension (eight cases, 50%), diabetes
mellitus (two cases, 16.7%), and hyperlipidemia (two cases,
16.7%).
The control group consisted of 16 subjects (mean age,
59 years; range, 51 to 68 years; male:female, 1:2.2). None
of the control subjects had ever had a cerebral event, and
MRI of the brain and carotid duplex scan study results were
normal in all. Permission to perform this study was given by
the Asan Medical Center Clinical Research Review Board,
University of Ulsan College of Medicine. Informed con-
sent was obtained from all patients included in this study.
The surgical procedures were carried out with regional
anesthesia with either cervical plexus block or cervical epi-
dural anesthesia. Intraoperative blood pressure was moni-
tored with arterial line in addition to standard anesthetic
monitoring. Systemic heparinization was given to all pa-
tients (5000 units, intravenously) before carotid clamping.
The ability to tolerate cross clamping was assessed with
evaluation of the level of consciousness and motor func-
tion, such as counting numbers and squeezing a squeaking
rubber doll placed in the contralateral hand. When the
patients had speech or motor dysfunction, a temporary
shunt was inserted within 2 minutes. Three patients
(16.7%) showed signs of altered consciousness that neces-
sitated shunting at the time of carotid cross clamping: two
with contralateral ICA occlusion and one without con-
tralateral disease. Routine patch angioplasty was performed
with optical 3.5 power magnification and polypropylene
5/0 and 6/0 continuous sutures. All patients were given
antiplatelet therapy (cilostazol or aspirin) after surgery, and
ICA volume flow was measured with duplex scan as soon as
the neck wound was healed (within 2 to 3 weeks). No
neurologic complications or mortality occurred in the 18
patients who underwent CEA.
A high-resolution unit (ATL HDI 3000, Advanced
Technology Laboratories, Bothell, Wash) with L7-4 or
L10-5 MHz transducers was used. Patients were examined
in the supine position with the shoulder slightly elevated
and the neck extended. The examination included a scan
and Doppler assessment of the carotid arteries. Longitudi-
nal and transverse scans of the entire common, external,
and internal carotid arteries were obtained from the clavi-
cle, including the carotid bifurcation to their disappearance
beyond the angle of the mandible. In the stenotic regions of
the ICA, volume flow measurements were repeated more
than three times and average values were obtained. The
same measurements were taken after surgery to assess the
preoperative and postoperative findings. Representative le-
sions were videotaped for later inspection and reevaluation.
All duplex scan study results were interpreted by two qual-
ified examiners who were unaware of the neurologic status
of the patient.
Localized in vivo 1H-MRS was performed on a GE
1.5T SIGNA system equipped with shielded gradients and
proton brain examination package (version 5.4, General
Electric Medical System, Milwaukee, Wis). T1-weighted
and T2-weighted MRIs were acquired, and T2-weighted
images were used for localized images. Image-guided stim-
ulated echo acquisition mode–spectra were obtained from
7-mL to 10-mL voxels in the middle cerebral artery (MCA)
territory of both hemispheres with the following acquisi-
tion parameters: repetition time  3.0 seconds, echo
time  30 milliseconds, number of scans  36 averages,
and number of excitation 2. All raw data were transferred
to a Sun Sparc-10 work station (SUN Computer, Inc,
Sunnyvale, Calif) and processed with Spectral Analysis/
General Electric software (General Electric Medical Sys-
tem) incorporated with low frequency filtering of residual
water signal removal, apodization with 0.5 Hz of exponen-
tial line broadening, zero filling of 8 k, Fourior transforma-
tion, and lorenzian to gaussian transformation according to
the same method as described by Kreis and Ross.7 The
metabolic peaks were fitted with the lorenzian line shape at
known frequencies of N-acetylaspartate at 2.02 ppm, crea-
tine at 3.03 ppm, choline and choline-containing com-
pounds at 3.22 ppm, and myo-inositol at 3.56 ppm. Total
creatine concentration was used as an internal reference for
the other metabolic peaks of the 1H-MR spectrum because
it is known to be relatively constant and tends to be resistant
to changes for many metabolic diseases. The relative ratios
of N-acetylaspartate/creatine, choline/creatine, and myo-
inositol/creatine were calculated.
Results were expressed as mean  standard deviation.
Quantitative assays were compared with the unpaired Stu-
dent t test or one-way analysis of variance, and categoric
data were compared with 2 test. Correlation between
parameters was evaluated with the Pearson or Spearman
correlation coefficient. Statistical calculations were per-
formed with SPSS for windows (release 8.0, SPSS, Inc,
Chicago, Ill). A P value less than .05 was considered
statistically significant.
RESULTS
Preoperative ICA volume flow measured with duplex
scan was severely decreased to less than 150 mL/min in all
18 patients (79.5  61.3 mL/min). After CEA, ICA
volume flow was increased to greater than 300 mL/min in
all patients (356.5  44.1 mL/min). Postoperative values
were significantly higher than preoperative values (P 
.00).
Fig 1 shows the typical 1H-MRS spectrum acquired
from the MCA territory in one representative subject of the
control group. The spectrum showed the normal metabo-
lite signals of the human brain. Table I shows the metabolic
changes in the MCA territory by 1H-MRS between the
control subjects and patients before and after CEA. For
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patients in the CEA group, N-acetylaspartate/creatine,
choline/creatine, and myo-inositol/creatine ratios ob-
served in the MCA territory before CEA were within the
normal limit, compared with the control group. But post-
operative values of N-acetylaspartate/creatine and cho-
line/creatine ratios were significantly increased in the MCA
territory of the ipsilateral hemisphere as compared with the
preoperative values (P .05) but not for the control group.
Postoperative value of myo-inositol/creatine ratio showed
no statistically significant difference. Fig 2 shows the
changes of 1H-MRS spectra of the MCA territory in one
representative patient in the CEA group before and after
CEA. Table II shows the metabolic changes in the con-
tralateral MCA territory by 1H-MRS between the control
subjects and patients before and after CEA. In this CEA
subgroup of patients, all metabolic ratios before and after
CEA were within the normal limit, compared with the
healthy subjects in the control group. However, postoper-
ative values of choline/creatine and myo-inositol creatine
ratios were significantly changed in the MCA territory of
the contralateral hemisphere as compared with the preop-
erative values (P  .05). In the CEA group, the patients
were analyzed again between the two subgroups: 10 pa-
tients with significant contralateral disease and eight pa-
tients without. No statistically significant difference was
found between them (Tables III and IV).
DISCUSSION
The most important finding of this study was that
postoperative increases of N-acetylaspartate/creatine and
choline/creatine ratios in the ipsilateral MCA territory
were statistically significant in patients with asymptomatic
ICA flow lesion and no visible infarction on MRI, as
compared with the preoperative values. No significant dif-
ferences were noted as compared with the healthy subjects.
In the contralateral MCA territory, postoperative increase
of choline/creatine ratio and decrease of myo-inositol/
creatine ratio were statistically significant, as compared with
the healthy subjects.
Neurospectroscopy is defined as the field of study result-
ing from MRS examination of the human brain.8 It mea-
sures neuronal markers, energy and redox states, specific
fuels of tissue respiration, maturation, and possibly myeli-
nation and provides diagnostic patterns of altered neuro-
chemistry. Positron emission tomography, and to a lesser
extent single photon emission computed tomography,8
magnetic resonance angiography, functional MRI, and
“diffusion-imaging,” address blood flow, glucose turnover,
and oxygen consumption, and positron emission tomogra-
phy and single photon emission computed tomography are
uniquely able to “image” targeted receptor ligands. How-
ever, until the advent of nuclear magnetic resonance, no
direct noninvasive assay of the products of gene expression,
the cerebral metabolites, was available. There were no
neuronal marker, no astrocyte marker, and no technique to
directly determine energy metabolism. These gaps are now
filled by neurospectroscopy, and with increased clinical
experience, a diagnostic need for MRS of the brain
emerges. Single-voxel 1H-MRS can measure the cerebral
metabolites for patients with various diseases.7,9-11 In gen-
eral, MRS is more sensitive than MRI in detection of
ischemic damage (from vascular or other diseases) and is
also diagnostic at a much earlier stage in cerebrovascular
disease.
For patients with stroke, the reduced N-acetylaspartate
levels and accumulation of lactate and choline in the in-
farcted lesion were often observed in other studies.7,12,13
Previously, we performed another study with MRS in pa-
tients with stroke and reported that patients with ICA flow
lesion and cerebral infarction (or ischemia) showed signif-
icantly decreased choline/creatine and increased N-acety-
laspartate/choline ratios in the periinfarct area after CEA,
compared with the control patients with cerebral infarction
who underwent only medical treatment.6 The N-acetylas-
partate/creatine and myo-inositol/creatine ratios also
seemed to be increased after CEA, albeit statistically insig-
nificant, and the metabolic changes in the periinfarct area
were more prominent in patients with the increased cere-
bral perfusion after CEA than in patients without changes
in perfusion. We concluded in the previous study that CEA
improves the cerebral metabolism resulting from the in-
creased perfusion at the periinfarct area in patients with
Fig 1. Representative 1H-MRS spectrum acquired from healthy
subject. Cho, Choline; Cr, creatine; NAA, N-acetylaspartate.
Table I. Metabolic changes in MCA territory after CEA
Metabolites
Control
(n  16)
Before CEA
(n  18)
After CEA
(n  18)
NAA/Cr 1.34  0.14 1.27  0.12 1.43  0.23*
Cho/Cr 0.83  0.10 0.78  0.11 0.85  0.13*
mI/Cr 0.54  0.10 0.55  0.10 0.56  0.13
All data are expressed as mean  standard deviation.
*Significant difference between patients before and after CEA: P  .05.
NAA, N-acetylaspartate; Cr, creatine; Cho, choline; mI, myo-inositol.
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ICA flow lesion and cerebral infarction (or ischemia). In-
creased perfusion after the CEA also correlated well with
clinical functional improvement (gait improvement) as re-
ported by Kim et al.14
In this study, for the patients with asymptomatic ICA
flow lesion and no visible infarction on MRI, we have
shown that the metabolic ratios of the ipsilateral and con-
tralateral MCA territories were within the normal limit as
compared with the healthy subjects. However, after CEA,
the N-acetylaspartate/creatine and choline/creatine ratios
in the ipsilateral MCA territory were statistically signifi-
cantly increased compared with the preoperative value. In
the contralateral MCA territory, the postoperative increase
of choline/creatine ratio and decrease of myo-inositol/
creatine ratio were statistically significant without change of
N-acetylaspartate/creatine ratio, as compared with the pre-
operative values. No significant differences were noted as
compared with the healthy subjects. This can be explained
by the following arguments.
First, the values of metabolite ratios were within normal
limits when preoperative and postoperative values were
separately compared with healthy control subjects. This is
not a surprising fact if one considers that a individual with
asymptomatic ICA stenosis is still neurologically healthy
and the value of cerebral metabolite ratio falls within nor-
mal range. But statistically significant changes (improve-
ment) were detected with comparison between the preop-
erative and postoperative values within the patient group.
Second, N-acetylaspartate is known as a neuronal
marker because it is found exclusively in neurons, and their
processes in the mature brain were previously well investi-
gated.12,13,15 The reduced N-acetylaspartate is known to
be associated with neuronal loss,10,16 which can begin to
fall as early as 2 hours after the onset of focal infarction.17
The continued N-acetylaspartate decline over the first 2
weeks after stroke does not merely reflect clearing of debris
from neurons killed at the initial outset but is evidence of
continuing neuronal loss after the acute period, possibly, in
the ischemic penumbra.18 Although we do not think that
the increased N-acetylaspartate after CEA means the cre-
ation of new neurons, the postoperative N-acetylaspartate/
Fig 2. Representative spectra of MCA territory in patients with asymptomatic ICA stenosis and no visible lesion on
MRI (A) before and (B) after CEA.
Table II. Metabolic changes in contralateral MCA
territory after CEA
Metabolites
Control
(n  16)
Before CEA
(n  18)
After CEA
(n  18)
NAA/Cr 1.34  0.14 1.26  0.16 1.30  0.16
Cho/Cr 0.83  0.10 0.80  0.12 0.83  0.15*
mI/Cr 0.54  0.10 0.61  0.12 0.58  0.10*
All data are expressed as mean  standard deviation.
*Significant difference between patients before and after CEA: P  .05.
NAA, N-acetylaspartate; Cr, creatine; Cho, choline; mI, myo-inositol.
Table III. Preoperative metabolite ratios between
patients with (n  10) and without (n  8) contralateral
disease in CEA group
Metabolites
With
contralateral
disease
Without
contralateral
disease P value
NAA/Cr 1.23  0.13 1.30  0.10 .55
Cho/Cr 0.80  0.09 0.75  0.13 .29
mI/Cr 0.53  0.07 0.57  0.13 .26
All data are expressed as mean  standard deviation.
NAA, N-acetylaspartate; Cr, creatine; Cho, choline; mI, myo-inositol.
Table IV. Postoperative metabolite ratios between
patients with (n  10) and without (n  8) contralateral
disease in CEA group
Metabolites
With
contralateral
disease
Without
contralateral
disease P value
NAA/Cr 1.44  0.31 1.42  0.16 .49
Cho/Cr 0.88  0.13 0.83  0.13 .92
mI/Cr 0.54  0.15 0.57  0.12 .57
All data are expressed as mean  standard deviation.
NAA, N-acetylaspartate; Cr, creatine; Cho, choline; mI, myo-inositol.
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creatine ratio showed a statistically significant increase from
the preoperative value, endorsing the authors’ contention
that the improved cerebral perfusion after CEA will posi-
tively affect the hemodynamically compromised brain, al-
though without neurologic symptoms (eg, better survival
of neuronal cells in the ischemic penumbra). In the con-
tralateral side, N-acetylaspartate/creatine ratio showed no
significant increase after CEA. Although postoperative ce-
rebral perfusion may be increased via the collateral circula-
tion in the contralateral side, it was not enough to reach
better survival of ischemic penumbra in patients with sig-
nificant contralateral disease or ischemic penumbra did not
exist in patients without contralateral disease.
Third, interpretation of the choline signal is not
straightforward because of the range of the choline-con-
taining compounds, and the N-acetylaspartate signal gives
useful information as discussed subsequently. The clinical
significance of an elevated or depressed choline signal is
largely undetermined. A number of new ideas concerning
the choline resonance and its component of cerebral me-
tabolites have emerged from clinical studies. Choline ap-
pears to contain contributions from phosphorylcholine and
glycerophosphorylcholine, a precursor to cell membrane
and the breakdown product of cell membrane, respectively.
Therefore, an increased choline signal is thought to be an
indicator of active demyelination in some circumstanc-
es.19,20 Cerebral ischemia may also increase extracellular
choline concentration by interfering with its removal by the
circulation and by enhancing its net production from phos-
pholipids. However, the brain is protected from excess
choline and choline deprivation by a refined system of
homeostatic mechanisms that maintain a level of extracel-
lular choline that, for its role as precursor, meets saturation
criteria in normal conditions. In this study, the preoperative
choline/creatine ratio was within the normal limit com-
pared with the healthy subjects. After CEA, the postoper-
ative choline/creatine ratio was increased statistically sig-
nificantly in the ipsilateral and contralateral MCA territories
as compared with the preoperative value but not with the
healthy subjects. Therefore, it can be postulated that in
patients with asymptomatic critical ICA stenosis, 1H-MRS
choline signal may be a marker of the perfusional status of
the brain: as the cerebral perfusion increases to a normal
state after CEA, the 1H-MRS choline signal may increase to
a normal value as compared with the preoperative value.
Total creatine concentration is known to be relatively
constant throughout the brain and tends to be relatively
resistant to changes for many metabolic diseases. There-
fore, it may be used as an internal reference for the other
metabolic peaks of the 1H-MR spectrum. The concentra-
tion of myo-inositol fluctuates more than any of the other
major compounds detected in the proton spectrum. Al-
though myo-inositol has been recognized as a cerebral
osmolyte and its cellular specificity is believed to be that of
an astrocyte marker, evidence is incomplete. Like choline,
the resonance intensity of myo-inositol has been labeled as a
breakdown product of myelin, but the evidence is particu-
larly indirect and rather weak on this point.
In this study, patients with asymptomatic ICA flow lesion
and no visible infarction on MRI showed no significant differ-
ence in cerebral metabolite ratio as compared with the healthy
subjects. But the postoperative values of N-acetylaspartate/
creatine and choline/creatine ratios in the ipsilateral MCA
territory were statistically significantly increased as compared
with the preoperative values, and no significant differences
were noted with the healthy subjects. In the contralateral side,
postoperative increase of choline/creatine ratio and decrease
of myo-inositol/creatine ratio were statistically significant as
compared with the preoperative values.
In conclusion, our data suggest that CEA seems to
improve the cerebral metabolism in patients with asymp-
tomatic ICA flow lesion and no visible infarction on MRI.
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